Folate supplements to prevent heart disease: "time is ripe" for clinical trials -- editorial.
This article was originally published in The Tan Sheet
Executive Summary
FOLATE SUPPLEMENTATION: "TIME IS RIPE" FOR CLINICAL TRIALS to determine whether folic acid supplements can prevent cardiovascular disease by reduc-ing homocysteine levels, Meir Stampfer, MD, Harvard School of Public Health, and Rene Malinow, MD, Oregon Regional Primate Research Center, suggested in an editorial in the Feb. 2 issue of New England Journal of Medicine. The editorial responds to a study by Jacob Selhub, PhD, Tufts University, et al., that appears in the same issue of the medical journal.